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Abstract 
This study was designed to determine the serum albumin, GGT and LDH level in relationship with the CD4 
count and hepatitis B and C coinfection in HIV patient. Sixty HIV patients aged 16 to 75 years classified 
according to the CD4 cell count value and with reference to HBV/HCV co-infection status were studied. Viral 
Immunochemical status of the patients was determined by ELIZA and Immunoblotting. CD4 cell count was 
estimated by flow cytometry while the plasma LDH, GGT and Albumin was estimated biochemically by 
spectrophotometry. The results showed a significantly higher  mean value in the plasma level of  albumin in 
HIV-monoinfected  patients with CD4 count of between 251-399cells/µl and  those with values of  ≥400 cells /µl 
than those with CD4count between 0-250 cells/µl. with p<0.05.  The results showed a significantly higher  mean 
value in the plasma level of  albumin in HIV-HBV patients with CD4 count of between 251-399cells/µl and  
those with values of  ≥400 cells /µl than those with CD4count between 0-250 cells/µl. with p<0.05.  In 
conclusion there was a biochemical alteration in the plasma level of Albumin in the HIV monoinfected and HIV-
HBV patients and this significant alteration  was also found to be directly proportional to CD4 cell count hence 
the need for the estimation of these parameters in the management of HIV infection. None of the patients was 
coinfected with HCV. 
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1. Introduction 
HIV patients with chronic HBV and/or HCV are more likely to die of liver disease and have a more rapid 
progression to Acquired Immunodeficiency Syndrome (AIDS) than patients solely infected with HIV. Blood 
samples were assayed for the presence of HIV 1/2antibodies, Hepatitis B Surface Antigen (HBsAg) and 
Hepatitis C antibodies HCVab [1]. The prevalence of HBV and HCV among HIV patients was 13% and 10%, 
respectively. This calls for integration of HBV and HCV prevention, and treatment into HIV programs. 
Liver disease caused by chronic hepatitis B Virus (HBV) and hepatitis C Virus (HCV) is emerging as a 
significant cause of morbidity and mortality among immunocompromised Human Immunodeficiency Virus 
(HIV) infected individuals [2].  HBV, HIV, and HCV have similar modes of transmission, and a high proportion 
of HIV infected adults are at increased risk of developing chronic HBV and HCV infections. This co-infection 
may result in serious medical complications such as increased risk for liver-related morbidity and mortality. 
Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections are common among HIV positive patients in 
our environment and rapid detection and investigation of these co-infections may attract better management to 
avoid complications such as liver cirrhosis, hepatocellular carcinoma, and thrombocytopenia [3]. 
Biochemical parameters could serve as pointers for early detection of liver disease and renal malfunction in HIV 
patients. Ruttmann et al., [4] Serum gamma-glutamyl transferase (GGT) has been widely used as an index of 
liver dysfunction.HIV binds to CD4 receptors on helper T-lymphocytes, monocytes, macrophages and neural 
cells. CD4 cells migrate to the lymphoid tissue where the virus replicates and then infects new CD4-positive 
cells. As the infection progresses, depletion or impaired function of CD4 cells predisposes to the development of 
immune dysfunction. 
AIDS appear as severe immunodeficiency and evidence of life-threatening infections and unusual tumors. The 
initial assessment should also 'stage' the disease. The most widely used staging system is the 1993 revision of the 
CDC's AIDS Surveillance Case Definition for Adolescents and Adults. 
According to this system, individuals are assigned a stage according to both a CD4 cell count category and a 
clinical one. The CD4 cell count categories are as follows: 
• CD4 count greater than or equal to 500 cells/mm3 or 29%. 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.19, 2015 
 
89 
• CD4 count equal to 200-499 cells/mm3 or 14%-28%. 
• CD4 count less than 200 cells/mm3 or less than 14%. 
People with high serum GGT have higher mortality, partly because of the association between GGT and other 
risk factors and partly because GGT is an independent predictor of risk. [4].  
LDH is often measured in HIV patients as a non-specific marker for pneumonia due to Pneumocystis jiroveci 
(PCP). Elevated LDH in the setting of upper respiratory symptoms in an HIV patient suggests, but is not 
diagnostic for, PCP. However, in HIV-positive patients with respiratory symptoms, a very high LDH level (>600 
IU/L) indicated histoplasmosis (9.33 more likely) in a study of 120 PCP and 30 histoplasmosis patients[5].The 
aim of this work is to determine levels of albumin, GGT and LDH in relationship with the CD4 count and 
hepatitis B and C coinfection in HIV patients. 
2. Materials and Methods 
2.1. Subjects 
A total of sixty subjects which consist of both male and female were recruited for the study. Sixty subjects of 
sero-positive HIV patients either and not co infected with hepatitis B and C viruses serves as test and no control. 
The sixty subjects were patients from federal medical center, Owo, Ondo State, Nigeria. This study took place 
between June 2014 and September 2014. 
Information were extracted and data were derived from them such as if drugs are been initiated and used and 
their demographic informations. The age ranges of these subjects were between 16 and 75years and their CD4 
counts was also a major consideration. 
2.2. Collection and handling of specimen 
Collection of blood samples was implemented according to current practices. Serum was used. Blood samples 
were collected by venapuncture into a plane red top bottle, centrifuged and separated. Serum was separated soon 
as possible to avoid haemolysis because extensive haemolysis may affect test performance. Extraction of serum 
were used for the determination of  anti-HCV, HBsAg, using  immunoblotting, ELISA, and 
immunochromatographic methods  and Gamma glutamyl transferase, Lactate Dehydrogenase and Albumin were 
carried out biochemically by spectrophotometry using the reagent kits of Randox. 
Samples were stored at 2-8oC not more than 24hours; they may be deep-frozen at -20oC. Repeated 
freezing/thawing cycles was avoided. Samples that have been frozen and defrosted more than 1-2 times were not 
used. 
2.3. Principle of HEPATITIS B surface Antigen (HBsAg) test Using Quick Profile HBsAg TEST. 
Hepatitis B surface Antigen test is a double antibody sandwich immunoassay. Colloidal gold conjugated anti-
HBsAg antibody complexes are dry-immobilized in the test device. When the sample is added, it migrates by 
capillary diffusion through the strip re-hydrating the gold conjugate complexes. If present, HBsAg will react 
with the gold conjugate complexes forming particles. These particles will continue to migrate along the strip 
until the Test Zone (T) where they are captured by anti-HBsAg in sample; no red line will appear in the Test 
Zone (T). The gold conjugate complexes will continue to migrate alone until they are captured by anti-HBsAg 
antibodies immobilized there and a visible red line appears. If there is no HBsAg in sample, no red line will 
appear in the Test Zone (T). The gold conjugate complexes will continue to migrate alone until they are captured 
in the Control Zone (C) by immobilized goat anti-mouse IgG antibody aggregating a red line, which indicates 
the validity of the test.  
2.4. Principle of HEPATITIS C VIRUSES (HCV) Using Quick Profile HCV ANTIBODY TEST 
Hepatitis Ab Test employs chromatographic lateral flow device in a cassette format. Colloidal gold conjugated 
goat anti-human IgG are dried and immobilized on the fiberglass strip. HCV antigens are immobilized at the 
Test Zone (T) and goat anti mouse IgG antibodies are immobilized at the Control Zone (C). When the sample is 
added, it migrates by capillary diffusion rehydrating the gold conjugate. If present in sample, HCV antibodies 
will bind the gold conjugate anti-human IgG and/or IgM forming complexes. These complexes will continue to 
migrate along the strip until the Test Zone (T) zone where they are captured by the HCV antigens to form a 
visible red line. The un-bound gold conjugate will continue to move and bind with goat anti- mouse IgG at the 
control Zone (C) forming a visible red line. If no HCV antibodies in sample, only a red line is appeared at the 
control Zone (C), which indicates the validity of the test.  
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2.5. Determination of serum activities of GGT 
Randox kit was used for the quantitative in vitro determination of GGT activities in the serum. 
PRINCIPLE (Colorimetric method): 
The substrate L –y- glutamyl- 3-carboxy-4- nitroanilide, in the presence of glycyglycine is converted by y-GT in 
the sample to 5-amino-2-nitrobenzoate which can be measured at 405nm . 
2.6. Determination of serum activities of LDH 
This reagent is intended for in vitro quantitative determination of lactate Dehydrogenase in serum or plasma. 
PRINCIPLE 
Kinetic determination of lactate Dehydrogenase according to the following reaction.  
Pyruvate +NADH + H+ → L-Lactate + NAD+ 
LDH-P activity (U/L) = ( OD/min) x 16030. 
2.7. Determination of plasma activities of ALBUMIN 
Randox kit was used for the quantitative in vitro determination of albumin activities in the serum and plasma. 
PRINCIPLE 
The measurement of serum albumin is based on its quantitative binding to the indicator 3,3’,5,5’-tetrabromo-m 
cresol sulphonephthalein  (bromocresol green, BCG). The albumin-BCG-complex absorbs maximally at 578nm, 
the absorbance being directly proportional to the concentration of albumin in the sample.  
3. Results 
COMPARATIVE STUDY OF SERUM ALB, GGT AND LDH IN HIV MONOINFECTED IN 
RELATIONSHIP TO CD4 COUNT. 
TABLE 1: CD4 (0-250 VS 251-399) 
 0-250 251-399 T- VALUE P- VALUE SIGNIFICANCE 
CD4 147.9±15.3 346.1±9.4 10.983134 ˂0.00001 SIGNIFICANT 
LDH 324.3±14.7 324.4±11.7 0.206988 0.418759 NOT SIGNIFICANT 
GGT 24.6±3.5 21.5±3.5 0.585108 0.281667 NOT SIGNIFICANT 
ALB 33.8±0.5 39.2±1.0 4.899743 1.8E.05 SIGNIFICANT 
 
TABLE 2:  0-250 VS ≥400 
 0-250 ≥400 T VALUE P VALUE SIGNIFICANCE 
CD4 147.9±15.3 518.3±18.2 13.622407 ˂0.00001 SIGNIFICANT 
LDH 324.3±14.7 334.6±18.3 0.379331 0.353335 NOT SIGNIFICANT 
GGT 24.6±3.5 23.3±1.4 0.377394 0.354048 NOT SIGNIFICANT 
ALB 33.8±0.5 40.7±1.1 4.608326 2.5E-05 SIGNIFICANT 
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TABLE 3: 251-399 VS ≥400 
 251-399 ≥400 T VALUE P VALUE SIGNIFICANCE 
CD4 346.1±9.4 518.3±18.2 7.141739 ˂0.00001 SIGNIFICANT 
LDH 324.4±11.7 334.6±18.3 0.406533 0.343316 NOT SIGNIFICANT 
GGT 21.5±3.5 23.3±1.4 0.535511 0.29775 NOT SIGNIFICANT 
ALB 39.2±1.0 40.7±1.1 -0.930536 0.178984 NOT SIGNIFICANT 
 
The results showed a significantly higher  mean value in the plasma level of  albumin in HIV-monoinfected  
patients with CD4 count of between 251-399cells/µl and  those with values of  ≥400 cells /µl than those with 
CD4count between 0-250 cells/µl. with p<0.05.  However there was no significant difference was obtained in the 
plasma level of LDH and GGT with p>0.05. No significant difference was obtained in the plasma values of 
LDH, GGT and Albumin in HIV-monoinfected with CD4 value of 251-399cells/µl and those with values 
between ≥400 cells /µl with p>0.05 (p>0.05)  (Tables 1, 2 and 3). 
 
COMPARATIVE STUDY OF SERUM ALB, GGT AND LDH LEVELS IN HIV+HBV IN 
RELATIONSHIP TO CD4 COUNT      
TABLE 4:  0-250 VS 251-399 
 0-250 251-399 T VALUE  P VALUE SIGNIFICANCE 
CD4 147.1±16.3 347.9±8.9 10.608019 ˂0.00001 SIGNIFICANT 
LDH 327.4±13.7 324.7±10.9 0.150982 0.440484 NOT SIGNIFICANT 
GGT 25.0±3.2 22.6±3.3 0.495321 0.311933 NOT SIGNIFICANT 
ALB 34.8±0.8 39.9±1.2 3.464452 0.000788 SIGNIFICANT 
 
TABLE 5:  0-250 VS ≥400 
 0-250 ≥400 T VALUE  P VALUE SIGNIFICANCE 
CD4 147.1±16.3 510.9±16.9 14.053985 ˂0.00001 SIGNIFICANT 
LDH 327.4±13.7 341.0±18.3 0.516368 0.304186 N0T SIGNIFICANT 
GGT 25.0±3.2 22.6±1.3 0.782236 0.219285 NOT SIGNIFICANT 
ALB 34.8±0.8 39.9±1.0 3.55086 0.00049 SIGNIFICANT 
 
TABLE 6: 251-399 VS ≥400 
 251-399 ≥400 T VALUE P VALUE SIGNIFICANCE 
CD4 347.9±8.9 510.9±16.9 7.095238 ˂0.00001 SIGNIFICANT  
LDH 324.7±10.9 341.0±18.3 0.647915 0.260283 NOT SIGNIFICANT  
GGT 22.6±3.3 22.6±1.3 0.059519 0.476414 NOT SIGNIFICANT 
ALB 39.9±1.2 39.9±1.0 0.500748 0.309581 NOT SIGNIFICANT 
 
The results showed a significantly higher  mean value in the plasma level of  albumin in HIV-HBV patients with 
CD4 count of between 251-399cells/µl and  those with values of  ≥400 cells /µl than those with CD4count 
between 0-250 cells/µl. with p<0.05.  However there was no significant difference  was obtained in the plasma 
level of LDH and GGT with p>0.05.No significant difference was obtained in the plasma values of LDH, GGT 
and Albumin in HIV-HBV  patients with CD4 value of 251-399cells/µl and those with values between ≥400 
cells /µl with p>0.05 (p>0.05). None of the patients was coinfected with HCV. 
 
 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.19, 2015 
 
92 
4. Discussion, Conclusion and Recommendation. 
Discussion 
The results showed a significantly higher mean value in the plasma level of albumin in HIV-monoinfected 
patients with CD4 count of between 251-399cells/µl and those with values of  ≥400 cells /µl than those with 
CD4count between 0-250 cells/µl.  The results showed a significantly higher mean value in the plasma level of 
albumin in HIV-HBV patients with CD4 count of between 251-399cells/µl and those with values of ≥400 cells 
/µl than those with CD4count between 0-250 cells/µl. These imply a direct proportional relationship between 
plasma albumin and CD4 cell count in HIV mono and coinfection with HBV. The findings agree with the report 
of  Olawumi and Olatunji, [6] that reported a significant positive correlations between pretreatment albumin and 
both pretreatment CD4 count and pretreatment weight and treatment weight and between post treatment albumin 
and both post-treatment CD4 cell count up to a count of 700 cells/mL and post treatment weight. Olawumi and 
Olatunji, [6] concluded that in developing countries where many patients may not be able to afford to pay for 
CD4 cell counts and viral load tests, which are the traditional markers for HIV disease, serum albumin would be 
a very useful surrogate test for predicting severity of HIV infection and for clinical monitoring of response to 
antiretroviral therapy. The findings of this work is also consistent with the report of  Kannangai et al., [7] that 
found a significant positive correlation of CD4+ T-cell counts and a negative correlation of viral load with 
albumin and DHEAS levels. Plasma albumin and, to some extent, DHEAS were reported by Kannangai et al., 
[7] as a promising prognostic markers in monitoring HIV infection. 
The results of this work could also be attributed to the fact that associations between lower serum selenium, 
lower CD4 count, and higher plasma viral load may be related to the frequent occurrence of low serum albumin 
and the acute phase response among individuals with more advanced HIV-1 infection [8]. 
4.1 Conclusion. 
This work revealed a biochemical alteration in the plasma level of Albumin in the HIV monoinfected and HIV-
HBV patients.  This significant alteration was also found to be directly proportional to CD4 cell count. 
4.2 Recommendation. 
 Estimation of plasma albumin, LDH, GGT and CD4 count is recommended in the management of HIV 
infection. 
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